Ultimovacs acquires Immuneed

The Norwegian biotech company Ultimovacs acquires the immunotherapy technology business of the Swedish company Immuneed AB.  The complementary technologies of the two companies provide a unique platform for development of novel vaccine solutions for treatment and possibly prevention of cancer. The acquired business has been named Ultimovacs AB and is now a fully-owned Swedish subsidiary […]

PCI Biotech with new research collaboration

PCI Biotech is initiating a scientific collaboration with Bavarian Nordic to boost their cancer treatment technology. Oslo Cancer Cluster member PCI Biotech has announced that it is initiating a preclinical research collaboration with Bavarian Nordic, a clinical stage biopharmaceutical corporation focused on developing state-of-the-art cancer immunotherapies and vaccines for infectious diseases. The two collaborators will […]

Get to know our new chairman

CEO of Ultimovacs Øyvind Kongstun Arnesen is the new chairman of Oslo Cancer Cluster. Get to know the guy! An Oslo born family man who likes the outdoors, and took the jump from hospital work to entrepreneurship by the way of the health industry.  Remarkably, before all this he dazzled the audience at the National […]

In need of start-up funding?

Are you and your cluster company in need of early stage funding? Apply for Innovasjonsrammen by the 10th of September and compete for important start-up money. Early financing for establishing companies is often limited, but can be absolutely crucial to get important projects off the ground. Therefore, Innovation Norway has created the special funding program […]

Can Norway compete internationally on health?

Can Norway take a leading international position within the health industry? This was the main question for one of our discussions at Arendalsuka last week. A report released in April this year shows a Norwegian health industry on the rise. However internationally, Norway is still comparatively small even compared to our Nordic neighbors. SEE VIDEO FROM […]

Tim: Pasienten som kommer hjem

Kan digitale løsninger lette hverdagen for pasienter som kommer hjem etter endt behandling? Det ville Oslo Cancer Cluster, sammen med Kreftforeningen og IKT Norge finne ut av på ettermiddagsprogrammet under Arendalsuka onsdag. Arrangement: PASIENTEN KOMMER HJEM – PAKKEFORLØP OG DIGITAL OPPFØLGING Kreftpasienten Tim Daglig leder for Oslo Cancer Cluster og konferansier Ketil Widerberg begynte med […]